Literature DB >> 27856261

Comparative studies on the skeletogenic mesenchyme of echinoids.

Takuya Minokawa1.   

Abstract

Skeletogenic mesenchyme cells in echinoids are suitable for studying developmental mechanisms, and have been used extensively. Most of these studies have been performed on species in the order Camarodonta, which are modern echinoids (subclass Euechinoidea) and are considered "model" echinoid species. In contrast, species belonging to other orders are studied less frequently, especially investigations of their molecular developmental biology such as gene regulatory networks. Recent studies on mesenchyme development in non-camarodont species suggest that these species are potential sources of comparative information to elucidate the mechanisms underlying skeletogenic mesenchyme development. In this review, the importance of using comparative data to understand development and evolution is discussed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echinoid; Micromere; Primary mesenchyme cell; Secondary mesenchyme cell; Skeletogenic mesenchyme cell

Mesh:

Year:  2016        PMID: 27856261     DOI: 10.1016/j.ydbio.2016.11.011

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  3 in total

1.  Notch-mediated lateral inhibition is an evolutionarily conserved mechanism patterning the ectoderm in echinoids.

Authors:  Eric M Erkenbrack
Journal:  Dev Genes Evol       Date:  2017-12-16       Impact factor: 0.900

2.  Cell type phylogenetics informs the evolutionary origin of echinoderm larval skeletogenic cell identity.

Authors:  Eric M Erkenbrack; Jeffrey R Thompson
Journal:  Commun Biol       Date:  2019-05-03

3.  Gene regulation of adult skeletogenesis in starfish and modifications during gene network co-option.

Authors:  Atsuko Yamazaki; Shumpei Yamakawa; Yoshiaki Morino; Yasunori Sasakura; Hiroshi Wada
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.